Vidyya Medical News Service
*
Volume 7 Issue 78 Published - 14:00 UTC 08:00 EST 19-March-2005 Next Update - 14:00 UTC 08:00 EST 20-March-2005
little clear gif used for spacer
.
*

College alcohol problems exceed previous estimates
Researchers report that unintentional fatal injuries related to alcohol increased from about 1,500 in 1998 to more than 1,700 in 2001 among U.S. college students aged 18-24.  Over the same period national surveys indicate the number of students who drove under the influence of alcohol increased by 500,000, from 2.3 million to 2.8 million.   more

*
Virginity pledges do not reduce STD risk: May encourage high risk sexual behavior
Young adults who take virginity pledges as adolescents are as likely to be infected with sexually transmitted diseases as those who do not take virginity pledges, Yale and Columbia University researchers report in the March 18 issue of Journal of Adolescent Health.  more

*
Yale authors raise concerns regarding regionalized heart attack care
Calls to regionalize the care of patients with heart attacks are premature, and do not account for potential unintended consequences, according to a commentary by Yale researchers published in today's Journal of the American Medical Association (JAMA).  more

 


*
Obtaining patient consent for clinical audit is unworkable without extra resources
Obtaining signed patient consent for audit purposes is difficult and is unlikely to be successful unless extra resources are made available, finds a study published online by the BMJ this week.  more

*
Temodar approved for glioblastoma multiforme
The Food and Drug Administration (FDA) has granted approval of a new indication for Temodar (temozolomide). The drug, used concurrently with radiotherapy and as maintenance therapy after radiotherapy, can extend the lives of adult patients newly diagnosed with glioblastoma multiforme (GBM), the most common form of malignant brain cancer.  more

*
FDA approves new drug to treat type 1 and type 2 diabetes
The Food and Drug Administration (FDA) today approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone.  more

*
Prescribing information: Symilin
Symlin will be the only therapy for the treatment of type 1 diabetes other than insulin. Patients with type 2 diabetes already have several other types of oral therapies available. . more

 
little clear gif used for a space